@article{JTD24270,
author = {Sheenu Sheela and Edward S. Kim and Kathryn F. Mileham},
title = {Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {9},
year = {2018},
keywords = {},
abstract = {Treatment of patients with advanced non-small cell lung cancer (NSCLC) has undergone dramatic changes in the recent decade. We have now established a treatment model based on precision medicine: detection of driver mutations and utilization of targeted agents as well as determination of programmed death-ligand 1 (PD-L1) status and integration of immunotherapy.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/24270}
}